microRNA-132 regulates gene expression programs involved in microglial homeostasis
Related Experiment Video
Updated: Jul 28, 2025

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
Hannah Walgrave1,2, Amber Penning3, Giorgia Tosoni3
1VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium.
Abstract:
microRNA-132 (miR-132), a known neuronal regulator, is one of the most robustly downregulated microRNAs (miRNAs) in the brain of Alzheimer's disease (AD) patients. Increasing miR-132 in AD mouse brain ameliorates amyloid and Tau pathologies, and also restores adult hippocampal neurogenesis and memory deficits. However, the functional pleiotropy of miRNAs requires in-depth analysis of the effects of miR-132 supplementation before it can be moved forward for AD therapy. We employ here miR-132 loss- and gain-of-function approaches using single-cell transcriptomics, proteomics, and in silico AGO-CLIP datasets to identify molecular pathways targeted by miR-132 in mouse hippocampus. We find that miR-132 modulation significantly affects the transition of microglia from a disease-associated to a homeostatic cell state. We confirm the regulatory role of miR-132 in shifting microglial cell states using human microglial cultures derived from induced pluripotent stem cells.
Insights
microRNA-132 (miR-132) is downregulated in Alzheimer's disease (AD). Restoring miR-132 shifts microglia to a healthy state, offering a potential therapeutic avenue for AD.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- microRNA-132 (miR-132) is significantly downregulated in Alzheimer's disease (AD) brains.
- Increasing miR-132 in AD mouse models improves pathologies and cognitive function.
- Further investigation is needed to understand miR-132's pleiotropic effects for therapeutic development.
Purpose of the Study:
- To identify molecular pathways targeted by miR-132 in the mouse hippocampus.
- To analyze the effects of miR-132 modulation on microglial cell states.
Main Methods:
- Utilized miR-132 loss- and gain-of-function approaches.
- Employed single-cell transcriptomics, proteomics, and in silico AGO-CLIP datasets.
- Confirmed findings using human induced pluripotent stem cell-derived microglia.
Main Results:
- miR-132 modulation significantly impacts the transition of microglia from a disease-associated to a homeostatic state.
- Identified specific molecular pathways regulated by miR-132 in the hippocampus.
- Demonstrated miR-132's regulatory role in microglial state shifts in human cell cultures.
Conclusions:
- miR-132 plays a crucial role in regulating microglial states, shifting them towards homeostasis.
- These findings highlight miR-132 as a potential therapeutic target for Alzheimer's disease.
- Understanding miR-132's molecular targets is key for developing effective AD treatments.
Related Concept Videos
MicroRNAs
Regulation of Expression at Multiple Steps

